Teresa F. Winslow has been named senior vice president, global business development and James Miskel has been appointed vice president, strategy and corporate development, MDS Pharma Services. Ms. Winslow will direct global business development efforts and Mr. Miskel will focus on strategic partnerships.
   
“I’m delighted to add these two experienced leaders to our senior management team,” said MDS Pharma Services president David Spaight. “Their skills and knowledge will allow us to seize emerging opportunities to accelerate the growth of our business.”
   
Ms. Winslow is an experienced executive leader of business development in the healthcare industry. She previously served as president, Dendrite Americas and senior vice president, Dendrite International, a supplier of sales force and marketing effectiveness solutions for the pharmaceutical industry. Ms. Winslow was responsible for operations, sales and marketing functions and led double-digit growth of the company’s largest division.  
   
Mr. Miskel joins the company from Wyeth Pharmaceuticals, where he was assistant vice president for business planning and strategy. He spent much of his career with McKinsey & Co. leading growth strategy, operational improvement, and acquisition work in the Americas and Europe for pharmaceutical and medical device companies.